Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
35.00
+7.50 (27.27%)
At close: Aug 10, 2026, 4:00 PM EDT
35.70
+0.70 (2.00%)
After-hours: Aug 10, 2026, 6:18 PM EDT

Obsidian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Last Close Price
35.006.2713.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Debt / Equity Ratio
0.070.060.04
Net Debt / Equity Ratio
-1.02-1.06-0.99
Net Debt / EBITDA Ratio
0.560.731.80
Net Debt / FCF Ratio
0.630.842.13
Quick Ratio
3.865.2410.46
Current Ratio
4.215.3110.75
Return on Equity (ROE)
--85.41%-
Return on Assets (ROA)
--48.51%-
Return on Capital Employed (ROCE)
-180.90%-144.30%-54.40%
SEC Filings: 10-K · 10-Q